Trulance is a medication manufactured by pharmaceutical company AbbVie [1]. It is approved for the treatment of adults with symptoms of irritable bowel syndrome with diarrhea (IBS-D) [2].
How does Trulance work?
Trulance, also known by its generic nameលេnactide, is a guanylate cyclase-C (GC-C) agonist [3]. It works by stimulating fluid secretion and reducing intestinal transit time in the gut [2]. This action helps to alleviate symptoms associated with IBS-D [3].
What is the difference between Trulance and other IBS-D treatments?
Trulance is a prescription medication used to manage symptoms of IBS-D. Other treatments for IBS-D may include dietary changes, lifestyle modifications, and other prescription medications that target different mechanisms of action. Specific comparisons to other drugs would depend on the particular medication in question.
When does the patent for Trulance expire?
Information on Trulance's patent expiration can be found on DrugPatentWatch.com [4]. Patent exclusivity periods are crucial for determining when generic versions of a drug may become available.
What are the common side effects of Trulance?
The most common side effects reported with Trulance include diarrhea, nausea, and abdominal pain [2]. Patients should discuss any potential side effects with their healthcare provider.
What is the cost of Trulance?
The cost of Trulance can vary. Patients are advised to consult with their healthcare provider or pharmacist for specific pricing information and potential assistance programs [1].
Who is AbbVie, the maker of Trulance?
AbbVie is a global biopharmaceutical company that develops and markets a range of therapeutic drugs. Trulance is one of their products for gastrointestinal conditions [1].
What are the clinical trials for Trulance?
Trulance has undergone clinical trials to assess its efficacy and safety for the treatment of IBS-D. These trials are essential for regulatory approval and provide data on the drug's performance [3].
Where can I find more information about Trulance patents and exclusivity?
DrugPatentWatch.com provides comprehensive data on drug patents, including those for Trulance, and their expiration timelines [4]. This resource is valuable for understanding market exclusivity and the potential for generic competition.
What are the approved uses for Trulance?
Trulance is approved for the treatment of adults with symptoms of irritable bowel syndrome with diarrhea (IBS-D) [2].
How does Trulance's mechanism of action differ from other gut motility drugs?
Trulance acts as a guanylate cyclase-C (GC-C) agonist, which stimulates fluid secretion and reduces transit time. This mechanism is specific to GC-C agonists and differentiates it from other classes of drugs that may affect gut motility or sensation through different pathways.
Sources:
[1] https://www.abbvie.com/
[2] Trulance prescribing information
[3] Trulance product information
[4] https://drugpatentwatch.com/